In atherosclerosis, many studies have supported the role of the chemokine receptor CCR5 and its ligands CCL3, CCL4, and CCL5 in triggering the progression of atherosclerosis, particularly in later stages of plaque. Here, CCR5 is linked to atherosclerosis.